Trabecular Thickening on Mammography Post-COVID Vaccine and RSV Vaccine: Case Report
Author Type(s)
Student
Document Type
Article
Publication Date
9-1-2024
DOI
10.1016/j.radcr.2024.05.045
Journal Title
Radiology Case Reports
Abstract
Ipsilateral axillary adenopathy post-COVID mRNA vaccine has been widely reported and guidelines for management have been established. Isolated changes of axillary tail trabecular thickening without associated adenopathy in the breast present a diagnostic dilemma and no official guidelines have thus far been reported. This finding has been reported after COVID mRNA vaccine and has never been reported with any other vaccine. We report on a patient with such changes on screening mammography 1.5 months after the fifth dose of a COVID-mRNA vaccine and 1 week after RSV vaccine. This raises the possibility that such changes can be seen with vaccines other than the COVID mRNA series of vaccines. The main differential diagnosis includes mastitis and inflammatory breast cancer. The transient nature of this finding with spontaneous resolution at diagnostic mammography and the vaccination history helps to establish the diagnosis and exclude breast cancer.
Recommended Citation
Siegel, A., Adam, R., Rubner, R., Bains, H., Ha, R., & Maldjian, T. (2024). Trabecular Thickening on Mammography Post-COVID Vaccine and RSV Vaccine: Case Report. Radiology Case Reports, 19 (9), 3729-3731. https://doi.org/10.1016/j.radcr.2024.05.045
